This protocol is judged by an institutional critique board, an independent team that opinions any medical trials involving human beings. If a analyze consists of a Schedule I drug, once the board approves the protocol as ethical, the researchers need to make an application for an investigational new drug (IND) amount in the FDA.Weiser urged social